Log in to save to my catalogue

Utilization of cardiac tests in anthracycline‐treated cancer survivors differs between young adults...

Utilization of cardiac tests in anthracycline‐treated cancer survivors differs between young adults...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_91b19d5336b6448f8c6b4602415a9bb5

Utilization of cardiac tests in anthracycline‐treated cancer survivors differs between young adults and children: A claims‐based analysis

About this item

Full title

Utilization of cardiac tests in anthracycline‐treated cancer survivors differs between young adults and children: A claims‐based analysis

Publisher

United States: John Wiley & Sons, Inc

Journal title

Cancer medicine (Malden, MA), 2023-12, Vol.12 (24), p.22056-22061

Language

English

Formats

Publication information

Publisher

United States: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Background
The Children's Oncology Group Guidelines recommend a cardiacechocardiogram, or comparable functional imaging, following therapy completion in survivors of childhood/adolescent cancers exposed to anthracyclines.
Methods
Using the 2009–2019 Merative™ MarketScan® Commercial Database, we examined real‐world utilization of cardiac te...

Alternative Titles

Full title

Utilization of cardiac tests in anthracycline‐treated cancer survivors differs between young adults and children: A claims‐based analysis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_91b19d5336b6448f8c6b4602415a9bb5

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_91b19d5336b6448f8c6b4602415a9bb5

Other Identifiers

ISSN

2045-7634

E-ISSN

2045-7634

DOI

10.1002/cam4.6801

How to access this item